Oncology Research and Treatment : Impact Factor & More
eISSN: 2296-5262pISSN: 2296-5270
Share this on:
Key Metrics
CiteScore 
3.6
H-Index
52
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.9
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Oncology Research and Treatment
Oncology Research and Treatment Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | KARGER |
| Language | English |
| Frequency | Irregular |
| General Details | |
| Language | English |
| Frequency | Irregular |
| Publication Start Year | 1986 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Oncology Research and Treatment ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Oncology Research and Treatment
Frontline pembrolizumab or methotrexate in elderly, frail, or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-HNSCC) - results of the randomized phase 2 study ELDORANDO (AIO-KHT-0115).
- 22 Dec 2025
- Oncology research and treatment
Lungenkarzinom: Aktuelle Entwicklungen zur Therapie
- 18 Nov 2025
- Oncology Research and Treatment
PharmaNews
- 18 Nov 2025
- Oncology Research and Treatment
PharmaNews
- 18 Nov 2025
- Oncology Research and Treatment
Society Bulletins
- 18 Nov 2025
- Oncology Research and Treatment
PharmaNews
- 18 Nov 2025
- Oncology Research and Treatment
Frontline pembrolizumab or methotrexate in elderly, frail, or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-HNSCC) - results of the randomized phase 2 study ELDORANDO (AIO-KHT-0115).
- 22 Dec 2025
- Oncology research and treatment
Lungenkarzinom: Aktuelle Entwicklungen zur Therapie
- 18 Nov 2025
- Oncology Research and Treatment
PharmaNews
- 18 Nov 2025
- Oncology Research and Treatment
PharmaNews
- 18 Nov 2025
- Oncology Research and Treatment
Society Bulletins
- 18 Nov 2025
- Oncology Research and Treatment
PharmaNews
- 18 Nov 2025
- Oncology Research and Treatment
FAQs on Oncology Research and Treatment
How long has Oncology Research and Treatment been actively publishing? 
What is the publishing frequency of Oncology Research and Treatment?
How many articles did Oncology Research and Treatment publish last year?
What is the eISSN & pISSN for Oncology Research and Treatment?
What is Citescore for Oncology Research and Treatment?
What is the H Index for Oncology Research and Treatment ?
What is SNIP score for Oncology Research and Treatment?
What is the SJR for Oncology Research and Treatment?
Who is the publisher of Oncology Research and Treatment?
